Fauci Gets COVID Again After Taking Pfizer’s Treatment — the Drug That Cost Taxpayers $10.5 Billion
Dr. Anthony Fauci said Tuesday he is experiencing a rebound of COVID-19 symptoms after taking Paxlovid, Pfizer’s COVID-19 antiviral pill. Taxpayers are on the hook for $10.5 billion worth of the experimental treatment, under a deal the White House cut with Pfizer.
Fauci tested positive for COVID-19 on June 15, despite being quadruple-vaccinated, initially experiencing “mild symptoms,” according to the NIAID.
- Due to his age he was put on a five day treatment of the expensive and rushed to market drug Paxlovid, which experts admit has a track record of causing a rebound of COVID, yet the CDC illogically continues to recommend it. Despite all common sense, logic, and science, the CDC will never in 1,000 years promote HCQ or ivermectin, vitamin C & D, and other effective, safe, cheap medications/supplements, just like they will never promote extended antibiotics for Lyme/MSIDS
- Despite testing negative (as if that means anything) for three days in a row, Fauci reverted back to positive on the fourth day after treatment
- His rebound felt worse than the first time he had COVID
- Please know that while Biden’s “Test to Treat” initiative which supposedly allows Americans who test positive for COVID at a pharmacy to obtain “free” antiviral pills on the spot, these “free” pills have cost the U.S. taxpayer $10.6 BILLION.
- Dr. David Gortler, pharmacologist, pharmacist, FDA and healthcare policy oversight fellow and FDA reform advocate at the Ethics and Public Policy Center, questions why the government continues to invest in Paxlovid given it’s lack of performance. He then rips the Pfizer study to shreds:
- While Pfizer claims the drug reduces hospitalization and death by nearly 90% in people with mild to moderate infections, nearly everyone who gets the existing COVID mutation will have mild or moderate disease.
- Pfizer limited its study to people who were unvaccinated and who faced the greatest risk from the virus
- An updated more recent analysis from 1,153 patients (out of a possible 2,246) showed a non-significant 51% relative risk reduction.
- Gortler wants to know why Biden gambled every tax dollar on ONE single drug from ONE single drugmaker, Pfizer, “…when they could have spent almost nothing and promoted the established safety and efficacy of hydroxychloroquine and ivermectin with an established, superior outcome.”